Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears Vascular Solutions' lower-cost sealing device:

This article was originally published in Clinica

Executive Summary

The US FDA has approved Vascular Solutions' PMA Supplement for its Diagnostic Duett sealing device - a less expensive version of its original Duett device tailored to treat diagnostic patients. The procoagulant in the new device is dosed for less-challenging diagnostic patients where substantial blood-thinning drugs are used less frequently, resulting in lower costs. The original Duett device is still effective for over 2.5 million diagnostic procedures in the US annually, says the Minneapolis, Minnesota firm, which this month plans to launch a flowable haemostat, D-Stat, that contains the same procoagulant components as that found in the Duett device.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT064561

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel